SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-05-019216
Filing Date
2005-07-11
Accepted
2005-07-11 17:10:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a2160620zsc13ga.txt SC 13G/A 13993
2 EXHIBIT 99.1 a2160620zex-99_1.txt EX-99.1 1070
3 EXHIBIT 99.2 a2160620zex-99_2.txt EX-99.2 1699
  Complete submission text file 0001047469-05-019216.txt   18902
Mailing Address 399 PARK AVENUE NEW YORK NY 10043
Business Address 399 PARK AVENUE NEW YORK NY 10043 2125591000
CITIGROUP INC (Filed by) CIK: 0000831001 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 05948755
SIC: 2836 Biological Products, (No Diagnostic Substances)